Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis.
BACKGROUND Chimeric antigen receptor (CAR) T-cell therapy has been compared with established non-CAR T treatments in several hematological malignancies, but the magnitude and consistency of benefit across diseases and comparators remain unclear. We conducted a systematic review and meta-analysis of comparative studies...